Artificial cornea study for severe corneal blindness
Part of Eyes & vision clinical trials.
This study tests an artificial cornea (a small plastic implant) to see if it can safely improve vision in people who are blind from corneal damage and cannot have a regular cornea transplant. It aims to help those with no other good treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are blind in both eyes, with vision worse than 0.05 (roughly "count fingers" or less) even with glasses.
- You are not able to do daily activities on your own because of poor vision.
- A standard cornea transplant is unlikely to work for you, or it would be too risky to do.
- Your eye pressure is normal, or well-controlled with treatment (below 21 mmHg).
- The back part of your eye (retina and optic nerve) is healthy enough to have visual potential.
- You are willing to join the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure called Xenia corneal lenticule in people with severe keratoconus or severe post-LASIK corneal thinning who want to avoid a corneal transplant. It aims to improve vision while checking safety and how well the new procedure works over time.
This study tests a new robot-assisted surgical technique for doing a full-thickness corneal transplant. The goal is to see if the robot can help make the surgery more precise and safer.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
This study tests a new approach to help prevent cornea transplant failure in people with high-risk conditions, such as blood vessels growing into the cornea. It aims to see if this treatment can improve transplant success.
This trial uses donated corneal tissue that was treated with a special light and riboflavin (collagen cross-linking) to strengthen it before transplant. The goal is to improve vision in people with severe keratoconus, a condition where the cornea bulges into a cone shape and gets very thin.
This study tests an artificial corneal implant called EndoArt for people with long-term corneal swelling who have run out of transplant options. The implant aims to reduce swelling and improve vision without needing a donor cornea.
Hear when a new Keratoprosthesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.